Is AC Immune (ACIU) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 03/18/26
AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate UpdateGlobeNewsWire • 03/13/26
AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PDSeeking Alpha • 12/15/25
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson's DiseaseGlobeNewsWire • 12/11/25
AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate UpdateGlobeNewsWire • 11/04/25
Earnings Preview: AC Immune (ACIU) Q3 Earnings Expected to DeclineZacks Investment Research • 10/28/25
First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune's ACI-19626 in Precision MedicineGlobeNewsWire • 10/24/25
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate UpdateGlobeNewsWire • 08/05/25
AC Immune (ACIU) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 07/29/25
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate UpdateGlobeNewsWire • 04/30/25
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's DiseaseGlobeNewsWire • 04/02/25
AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025GlobeNewsWire • 03/25/25
AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate UpdateGlobeNewsWire • 03/13/25
AC Immune (ACIU) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 03/05/25
Down -9.7% in 4 Weeks, Here's Why You Should You Buy the Dip in AC Immune (ACIU)Zacks Investment Research • 02/13/25
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's PatientsBenzinga • 11/14/24
AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024GlobeNewsWire • 07/31/24